Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Custodiol vs Enriched Ringer's in TAAA Repair
NCT02327611Phase 4Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Feb 2015
- Primary completion
- Jan 2018
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of HTK Custodiol in acute kidney injury (AKI) (2 arms), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Acute Kidney Injury at 2 weeks. Started Feb 2015; status: completed.
02
Drugs
HTK Custodiol
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02327611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02327611.